---
title: "Cycurion Announces Reverse Stock Split to Maintain Nasdaq Listing"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/297338186.md"
description: "Cycurion (CYCU) announced a 1-for-8 reverse stock split to maintain Nasdaq listing compliance. Effective August 28, 2026, the split reduces shares from ~25.8 million to ~3.23 million. The move aims to meet minimum bid price rules without altering par value or authorized shares. Fractional shares will be paid in cash. While recent analyst ratings suggest a Buy with a $7 target, AI analysis rates CYCU as Neutral due to weak financial performance and technical pressures."
datetime: "2026-08-28T13:56:26.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/297338186.md)
  - [en](https://longbridge.com/en/news/297338186.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/297338186.md)
generator: "portal-rs"
---

# Cycurion Announces Reverse Stock Split to Maintain Nasdaq Listing

Cycurion ( (CYCU) ) has issued an announcement.

Cycurion, Inc. has implemented a 1‑for‑8 reverse stock split of its common shares, following board approval on August 13, 2026 and stockholder authorization at the July 23, 2026 annual meeting. The split, filed in Delaware on August 27, 2026, takes effect with the start of trading on August 28, 2026 on the Nasdaq Global Market under the existing ticker CYCU, with a new CUSIP assigned.

At the effective time, every eight issued and outstanding shares will be combined into one share, cutting the share count from about 25.8 million to roughly 3.23 million without changing par value or authorized shares. The move is designed to support compliance with Nasdaq’s minimum bid price rules, and will leave percentage ownership largely unchanged, aside from cash-in-lieu payments for fractional shares and proportionate adjustments to equity awards and convertible securities.

The most recent analyst rating on (CYCU) stock is a Buy  
 with a $7.00 price target.  
 To see the full list of analyst forecasts on Cycurion stock,  
 see the CYCU Stock Forecast page. 

**Spark’s Take on CYCU Stock**

According to Spark, TipRanks’ AI Analyst, CYCU is a Neutral.

CYCU scores low primarily due to very weak financial performance (steep revenue contraction, extreme losses, and meaningful cash burn), which outweighs balance-sheet improvement (zero reported debt). Technicals also remain pressured with the stock trading below major moving averages. Corporate events provide some support via new contracts, acquisitions, and IP wins, but listing-compliance and dilution/financing risks keep the overall score restrained.

To see Spark’s full report on CYCU stock,  
 click here. 

**More about Cycurion**

Cycurion, Inc., based in McLean, Virginia, is a cybersecurity and IT solutions provider focused on secure, AI-enhanced services for government, healthcare and corporate clients worldwide. Through its ARx platform and subsidiaries Axxum Technologies, Cloudburst Security and Cycurion Innovation, the company specializes in cybersecurity, program management and business continuity offerings.

**Average Trading Volume:** 18,148,520

**Technical Sentiment Signal:** Strong Sell

**Current Market Cap:** $11.85M

For an in-depth examination of CYCU stock, go to TipRanks’ Overview page.

### Related Stocks

- [CYCU.US](https://longbridge.com/en/quote/CYCU.US.md)
- [CYCUW.US](https://longbridge.com/en/quote/CYCUW.US.md)

## Related News & Research

- [Cycurion Announces ~$800,000 in Annual Contract Spend from Pharma AI CoE, NACCHO and Commercial Wins](https://longbridge.com/en/news/298357365.md)
- [Cycurion Lands Record Long-Term Government Contract](https://longbridge.com/en/news/294558050.md)
- [Cotiviti index shows healthcare AI adoption outpaces governance, cybersecurity readiness](https://longbridge.com/en/news/298315642.md)
- [ZAWYA: ManageEngine to show AI-powered cybersecurity at GISEC](https://longbridge.com/en/news/298210261.md)
- [Nasdaq, Inc. $NDAQ Shares Purchased by NewEdge Advisors LLC](https://longbridge.com/en/news/298572037.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**